Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06435884

Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101

CIC101-01-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Atrophic Scar

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Samsung Medical Center

Seoul, South Korea

About this study

The long-term safety of TRTP-101 was evaluated by participants in the CIC101-01 clinical trial and followed up for 5 years for serious adverse events.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Received TRTP-101 in clinical trial CIC101-01
  • Provided written informed consent to participate in this study

Exclusion criteria

  • Judged to be unsuitable to participate in this long-term follow-up

Treatment and study plan

Primary outcomes

  1. Serious Adverse Event

    Time frame: Up to 5 years

    SAE will be collected

Secondary outcomes

  1. Mean percent change in atrophic scar volume

    Time frame: 6, 12, 18 and 24 months

    The depressed volume of atropic scar is measured at baseline in study CIC101-01

  2. Patient's Satisfaction

    Time frame: 6, 12, 18 and 24 months

    Patient's Satisfaction with treatment scored by a 100-mm VAS(Visual Analogie Scale). On this scale, 0 indicates no satisfaction and 100 indicate extreme satisfaction.

Sponsors and collaborators

Lead sponsor

CellinCells

Industry

Registry information

Official study title

Long-Term Follow-up of Adult With Atrophic Scars Treated With TRTP-101 in Study CIC101-01

Important dates

Study start
2024
Primary completion
2029
Study completion
2029
First posted
May 30, 2024
Registry last updated
Mar 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.